retinitis, duodenal and/or colonic involvement, or dissemiCytomegalovirus (CMV) is a significant cause of morbidity nated disease. 2-4 CMV infection after OLT has been linked to in immunosuppressed patients. It is characterized in the liver decreased patient survival, particularly in studies published by parenchymal microabscesses, usually containing CMV-inbefore the availability of CMV-specific antivirals. 2,3,5-10 Stratta fected cells. However, not all hepatic microabscesses are due et al. 6 found that CMV infection in OLT recipients is associto CMV infection. In 1992, we described ''mini'' microabscess ated with increases in the duration of the peritransplant hos-(MMA) syndrome, a distinct clinical syndrome that occurs pital stay (38-80 days) and the average costs of these admisin transplanted livers. This report analyzes the clinical and sions (US$100,000-250,000). laboratory features of 57 cases of MMA syndrome occurring CMV infection usually occurs in the first 3 months after in 52 patients and compares these with 19 biopsy-proven OLT.
retinitis, duodenal and/or colonic involvement, or dissemiCytomegalovirus (CMV) is a significant cause of morbidity nated disease. [2] [3] [4] CMV infection after OLT has been linked to in immunosuppressed patients. It is characterized in the liver decreased patient survival, particularly in studies published by parenchymal microabscesses, usually containing CMV-inbefore the availability of CMV-specific antivirals. 2,3,5-10 Stratta fected cells. However, not all hepatic microabscesses are due et al. 6 found that CMV infection in OLT recipients is associto CMV infection. In 1992, we described ''mini'' microabscess ated with increases in the duration of the peritransplant hos-(MMA) syndrome, a distinct clinical syndrome that occurs pital stay (38-80 days) and the average costs of these admisin transplanted livers. This report analyzes the clinical and sions (US$100,000-250,000). laboratory features of 57 cases of MMA syndrome occurring CMV infection usually occurs in the first 3 months after in 52 patients and compares these with 19 biopsy-proven OLT. 2, 4, 6 CMV infection of the liver tends to be focal and cases of CMV infection. The diagnosis of MMA syndrome can may affect hepatocytes, bile duct epithelium, endothelium, only be made histologically. The microabscesses are smaller or any combination of these sites. Infected cells often contain and more numerous than in CMV infection, and there are no a single large eosinophilic nuclear inclusion surrounded by viral inclusions present. CMV DNA could not be detected in a halo, and/or numerous amphophilic granular cytoplasmic liver biopsy specimens with MMAs by using ''nested'' polyinclusions. 11 In the hepatic lobule, the infected cells are often merase chain reaction (PCR), indicating that MMA syndrome surrounded by a collection of neutrophils, forming a miis not caused by CMV infection. The pattern of liver enzyme croabscess. Occasionally a microabscess may lack morphoand bilirubin elevation is predominantly hepatocellular, with logically infected cells. 12 In this setting, the presence of mitransaminase levels elevated, on average, six to eight times croabscesses, even in the absence of typical CMV infected the upper limit of normal. The clinical features of MMA syn-cells, could be interpreted as evidence of CMV infection. drome are that it predominantly affects female (40 of 52 paCurrently, CMV infection in OLT recipients can usually tients) orthotopic liver transplant (OLT) recipients of all ages be successfully treated with ganciclovir. 3, 6, 13 Because of the (range, 11 months to 66.9 years). MMA syndrome is unrelated significant costs of untreated CMV infection in OLT recipito the indication for initial OLT and tends to occur later after ents, several groups have stressed the need for a high index transplantation than CMV infection (median, 91 days post-of suspicion for CMV infection post-OLT and have supported OLT vs. 32 days for CMV hepatitis). Although the etiology an aggressive approach to the diagnosis and treatment of of MMA syndrome is not clear, it does not appear to adversely CMV infection. 2, 8, 13, 14 However, ganciclovir therapy is expenaffect graft or patient survival. (HEPATOLOGY 1997;26:192-sive in terms of both nursing time and the cost of the drug.
197.)
Intravenous therapy with ganciclovir also carries the risk of systemic bacterial infection and other complications of Cytomegalovirus (CMV) infection is a major cause of mor-intravenous access in this already-compromised population. bidity in immunosuppressed patients, particularly transplant In 1992, we described a novel lesion, ''mini''-microabrecipients. 1 In orthotopic liver transplant (OLT) recipients, scesses (MMAs), seen in 14 liver biopsy specimens from CMV infection can result in hepatitis, pneumonitis, chorio-OLT recipients. 15 When MMAs were first seen, they were considered evidence of CMV infection and treated accordingly. However, as our experience grew, MMAs appeared Abbreviations: CMV, cytomegalovirus; OLT, orthotopic liver transplant; MMA, minihistologically and clinically distinct from CMV-associated microabscess; AST, aspartate transaminase; ALT, alanine transaminase; PCR, polymermicroabscesses. MMAs were smaller and more numerous ase chain reaction; CI, confidence interval.
than CMV-associated microabscesses and were not associated of the date of liver biopsy were reviewed. Fourteen needle liver biopsy specimens with MMA syndrome, 19 with CMV inclusion bodies present, and 28 with neither CMV infection nor MMA were studied with the PCR for evidence of CMV DNA. ln(time). Confidence intervals (95%) for estimates of survival ad-PCR was performed on DNA extracted from unstained 5-mm tissue justed for age, sex, and MMA status were estimated using Greensections of formalin-fixed, paraffin-embedded liver biopsy specimens wood's formula. 17 The study protocol conformed to the ethical using a technique previously described. 16 In brief, DNA was extracted guidelines of the 1975 Declaration of Helsinki. by direct boiling of unstained tissue sections that had been deparaffinized in xylene and 100% ethanol. Positive and negative controls con-RESULTS sisted of a paraffin section of cytomegalovirus-infected lung and an There was a wide variety of primary indications for the 1 minute, 64ЊC for 2 minutes, and 72ЊC for 2 minutes. Ten percent initial OLTs in these patients (Table 1) , including fulminant of the initial PCR reaction was subsequently used as a template for an additional PCR of 35 cycles using the following internally ''nested'' hepatic failure, cirrhosis due to ethanol abuse and/or hepatioligonucleotide primers: 5-TCTGATTCTCTGGTGTCACC-3 and 5-tis C infection, biliary cirrhosis, both primary and secondary, TCCTCCTCTTCCTCATCACT-3 (CMV-MIE gene), 5-CGGTTC-and cryptogenic cirrhosis. Patients with MMAs showed a AGGGTCAGAATCTG-3 and 5-CCATACGCCTTCCAATTCGG-3 wide age range, with a median age at the time of first OLT (CMV-LA gene), and 5-TCCTGAGGAGAAGTCTGCC-3 and 5-CCT-of 40.6 years (range, 11 months to 66.4 years). There was a ATCAGAAACCCAAGAGTC-3 (human b-hemoglobin), resulting striking female predominance in patients with MMAs, with in PCR products of 120, 89, and 165 base pairs, respectively. Condi-40 of the patients being female and 12 male (P õ .0001).
tions for the second-round PCR were the same as for the first except Sex of the liver donor was not significantly associated with that an annealing temperature of 54ЊC rather than 64ЊC was used.
MMA syndrome (Table 2) . Thirty-three of the MMA patients
The resulting PCR product was resolved by electrophoresis through were CMV immunoglobulin G antibody-positive before an agarose gel and directly visualized by UV illumination.
OLT, whereas 27 of their donors were positive. Nine patients
The effects of OLT donor and recipient gender were analyzed by x 2 analysis. The time from OLT to diagnosis and the peak bilirubin with MMA syndrome had negative pre-OLT CMV serology and liver enzyme levels were compared between MMA patients and for both recipient and donor, whereas data were incomplete those with biopsy-proven CMV infection assuming nonparametric in a further 2. For patients with CMV, in 16 cases either the distribution using the Mann-Whitney U test. Statistical analysis of donor (12 cases) and/or the recipient were CMV IgG positive, survival was performed with age categorized into quintiles of the whereas data were incomplete for the remaining 3. There was a significant difference in the time from OLT 57 or more years of age). Cox proportional hazards survival models to diagnosis of either CMV infection or MMA syndrome.
were used to estimate 1-and 5-year patient and graft survival rates.
Although there was some overlap, CMV occurred at a median tal finding of marked elevation of transaminase levels detected through routine blood work before an outpatient OLT clinic visit. For several patients, liver enzyme levels had been measured daily for 1 or more days before liver biopsy. The increase in transaminase levels occurred suddenly, over only 1 or 2 days. These biochemical abnormalities would result in sufficient clinical concern for a liver biopsy to be performed. The elevated transaminase levels would then resolve over several days (Fig. 1 ). Peak bilirubin concentration was significantly higher in patients with CMV syndrome, with a median peak of 78 mmol compared with 26 mmol in patients with MMA syndrome (P Å .004, Table 3 ). AST and ALT levels were both significantly greater in patients with MMA, with median values of 241 U/L and 350 U/L, compared with 102 U/L and 164 U/L in patients with CMV hepatitis (P Å .0001 and .014, respectively). Alkaline phosphatase levels were not significantly different between these two groups. The initial histological distinctions between MMA syndrome and CMV infection was borne out by reviewing liver biopsy specimens from a larger number of patients. The microabscesses were smaller in MMA syndrome and more numerous than those in CMV infection (Figs. 2 and 3 and Table  4 ). MMAs were confined to the hepatic lobules, with no OLT approximately 6 years before this episode of MMA syndrome for a In contrast, 18 of 19 biopsy specimens with CMV inclusion diagnosis of cryptogenic cirrhosis. She was being investigated for chronic bodies were positive for DNA by PCR. The one biopsy speci-diarrhea when it was noted that her ALT and AST levels were elevated. The men with CMV inclusions that was negative for CMV DNA increase in transaminase levels was not associated with onset of any new was presumably a consequence of a lack of an infected cell in the tissue section used for DNA extraction. In the control group of 28 liver transplant biopsy specimens without CMV inclusions or MMAs, 11 (39%) were positive for CMV DNA by PCR. The positive and negative controls run in parallel with the tested samples reacted appropriately. could not be detected by nested PCR. The biochemical features that help distinguish MMA syndrome from CMV infection include a greater elevation of AST and ALT levels but a lower peak bilirubin concentration than that observed in CMV infection. However, there is overlap between the two conditions with respect to clinical and biochemical features. tis in our review of OLT liver biopsies. Consequently, we found that MMA syndrome was more likely than CMV hepatitis if microabscesses were present in liver biopsy specimens spectively, whereas the estimated 1-and 5-year graft survival from patients who were 3 or more months post-OLT. MMA rates were 66.7% (95% CI 62.6-70.8) and 57.2% (95% CI syndrome predominantly affects female OLT recipients but 52.9-61.5), respectively. Patient survival was not dependent is not related to the indication for first OLT or the age of on recipient age or sex (P Å .74 and .58, respectively; Table patients. Importantly, MMA syndrome does not appear to 5) and graft survival was also not affected by recipient age have a negative effect on either patient or graft survival. or sex (P Å .53 and .32, respectively). There was little eviThe Kaplan-Meier plots (Fig. 4) show an apparent benefidence to suggest that the proportional-hazards assumption cial effect of MMA syndrome on both patient and graft surwas violated for patient and graft survival (for patient sur-vival. However, MMA syndrome occurs a variable time after vival, P Å .71 across ages and .23 across sexes; for graft OLT (range, 4-2,186 days). Most MMA patients are ''selected'' survival, P Å .06 across ages and .10 across sexes).
from the pool of patients who survive the peri-transplantation period. Thus, the MMA group has relatively little graft or DISCUSSION patient loss in the perioperative period; however, the KaplanMeier plots then parallel those for all OLT recipients. This MMA syndrome is a histologically diagnosed syndrome explains, at least in part, the apparent benefit for patient and characterized by numerous, small microabscesses confined graft survival in patients with MMA syndrome seen in these to the hepatic lobules. These features serve to distinguish plots. Incorporating the time post-OLT to diagnosis of MMA MMA syndrome from CMV infection in which the microabinto the proportional-hazards model as a time-dependent scesses are larger and in which biliary epithelium and endovariable controls for this potential source of bias. With this thelial cells are also infected. In addition, CMV inclusion modeling, MMA syndrome had no significant effect on pabodies are not found in MMA syndrome, and CMV DNA tient or graft survival. The typical presentation of MMA syndrome is of a clinically well female OLT recipient who has recovered from the perioperative OLT period and is attending a routine OLT outpatient appointment. Significant elevation of transaminase levels is detected on pre-outpatient clinic blood work. The elevated transaminase levels result in sufficient concern at the outpatient visit for an urgent liver biopsy to be arranged. This liver biopsy shows the typical histological appearance of MMA syndrome. The liver enzymes return to their usual level over several days.
Early in our experience with minimicroabscess syndrome we were concerned that the MMAs were caused by CMV. As our experience increased it became apparent that the clinical and histological features of MMA syndrome were quite distinct from CMV infection. However, the strongest evidence that CMV infection is not the cause of MMA syndrome comes from the CMV PCR results. CMV DNA could not be detected in any of the 14 MMA biopsy specimens tested, whereas the between circulating sex hormones and sex hormone receptors could be responsible. However, MMAs were also detected in patients who received a liver from a same-sex donor. MMA syndrome is not related to the indication for first OLT, and therefore does not appear to be due to a recurrence of the disease that resulted in OLT. Additionally, MMA syndrome is usually diagnosed 2 or more months after OLT, when most patients have recovered from the surgery. This implies MMA syndrome is not a consequence of the transplantation surgery. Finally, MMAs are not age specific and have been detected in liver biopsy specimens from pediatric and adult OLT recipients. Viral agents other than CMV implicated in viral hepatitis post-OLT include herpes simplex, Epstein-Barr virus, and adenovirus. [21] [22] [23] [24] [25] [26] Histologically, herpes simplex-associated hepatitis has areas of coagulative necrosis not confined to the hepatic lobule, and occasional hepatocytes at the edge of the necrotic foci contain nuclear inclusions.
21,24 Epstein-Barr virus infection has a variable appearance that ranges from a sinusoidal lymphocytosis, to a monomorphic immunoblastic lymphoma-like infiltrate of liver parenchyma. 21 These appearances are characteristic and sufficient to discriminate these infections from MMAs.
Microabscess formation can occur with adenovirus-associated hepatitis. 23, 26 However, areas of coagulative necrosis similar to, but smaller than, those observed in herpes simplex-associated hepatitis are described in adenovirus-associated hepatitis, and intranuclear inclusion bodies are typically present.
21,23-25 Additionally, adenovirus-associated microabscesses are larger than those found in CMV infection, distinguishing it from MMA syndrome.
21,23 Adenoviral hepatitis has predominantly been reported in pediatric OLT recipients, particularly in the first 3 months after OLT, and up to 45% of pediatric OLT recipients with invasive adenoviral infection die. [21] [22] [23] [24] 26 For these reasons, adenoviral hepatitis in OLT recipients appears histologically and clinically distinct from MMA syndrome. 
